A study of analytical methods for the determination of propofol in blood

Archives of Pharmacal Research

Volumn 37, Issue 2, 2014, Pages 157-167

  Han, Eunyoung ^a  

^a Duksung Women's University   (South Korea)

Author keywords

GC MS; HPLC; LC MS MS; Propofol abuse; Propofol blood analysis

Indexed keywords

ANESTHETICS, INTRAVENOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIMIT OF DETECTION; PROPOFOL; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84894081977     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0265-5     Document Type: Review

References (43)

1. Abad-Santos, F.; M.A. Gálvez-Múgica, M.A. Santos, J. Novalbos, S. Gallego-Sandín, P. Méndez, C. Casimiro, and F. Gilsanz. 2003. Pharmacokinetics and pharmacodynamics of a single bolus of propofol 2 % in healthy volunteers. Journal of Clinical Pharmacology 43: 397-405.
2. Albanese, J.; C. Martin, B. Lacarelle, P. Saux, A. Durand, and F. Gouin. 1990. Pharmacokinetics of long-term propofol infusion used for sedation in ICU patients. Anesthesiology 73: 214-217.
3. Bajpai, L.; M. Varshney, C.N. Seubert, and D.M. Dennis. 2004. A new method for the quantitation of propofol in human plasma: efficient solidphase extraction and liquid chromatography/APCI-triple quadruple mass spectrometry detection. Journal of Chromatography B 810: 291-296.
4. Bajpai, L.; M. Varshney, C.N. Seubert, S.M. Stevens Jr, J.V. Johnson, R.A. Yost, and D.M. Dennis. 2005. Mass spectral fragmentation of the intravenous anesthetic propofol and structurally related phenols. Journal of the American Society for Mass Spectrometry 6: 814-824.
5. Baselt, R.C.; and R.H. Carvey. 2008. Disposition of toxic drugs and chemicals in man, 8th ed. Foster City: Biomedical Publications.
6. Beaudry, F.; S.A. Guénette, A. Winterborn, J. Marier, and P. Vachon. 2005. Development of a rapid and sensitive LC-ESI/MS/MS assay for the quantification of propofol using a simple off-line dansyl chloride derivatization reaction to enhance signal intensity. Journal of Pharmaceutical and Biomedical Analysis 39: 411-417.
7. Bienert, A.; Z. Zaba, S. Dyderski, M. Ogrodowicz, and L. Drobnik. 2005. Long-term stability of propofol in human plasma and blood in different storage conditions. Acta Poloniae Pharmaceutica 62: 95-97.
8. Bleeker, C.; T. Vree, A. Lagerwerf, and B.E. Willems-van. 2008. Recovery and long-term renal excretion of propofol, its glucuronide, and two di-isopropylquinol glucuronides after propofol infusion during surgery. British Journal of Anaesthesia 101: 207-212.
9. Chao, T.C.; D.S.T. Lo, P.P.S. Chui, and T.H. Koh. 1994. The first fatal 2,6-di-isopropylphenol (propofol) poisoning in Singapore: a case report. Forensic Science International 66: 1-7.
10. Cohen, S.; F. Lhuillier, Y. Mouloua, B. Vignal, P. Favetta, and J. Guitton. 2007. Quantitative measurement of propofol and in main glucuroconjugate metabolites in human plasma using solid phase extraction-liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 854: 165-172.
11. Colucci, A.P.; R. Gagliano-Candela, L. Aventaggiato, D.A. De, S. Leonardi, G. Strisciullo, and F. Introna. 2013. Suicide by self-administration of a drug mixture (propofol, midazolam, and zolpidem) in an anesthesiologist: The first case report in Italy. Journal of Forensic Sciences 58: 837-841.
12. Cuadrado, A.; G. Solares, S. González, B. Sánchez, and J.A. Armijo. 1998. Propofol concentrations in whole blood: influence of anticoagulants and storage time. Methods and Findings in Experimental and Clinical Pharmacology 20: 297-300.
13. Cussonneau, X.; E. De Smet, K. Lantsoght, J. Salvi, M. Bolon-Larger, and R. Boulieu. 2007. A rapid and simple HPLC method for the analysis of propofol in biological fluids. Journal of Pharmaceutical and Biomedical Analysis 44: 680-682.
14. Dawidowicz, A.L.; A. Fijalkowska, A. Nestorowicz, and E. Fornal. 2001. The influence of blood sample storage time on the propofol concentration in plasma concentration in plasma and solid blood elements. Biomedical Chromatography 15: 408-412.
15. Dawidowicz, A.L.; and E. Fornal. 2000. The advantages of cell lysis before blood sample preparation by extraction for HPLC propofol analysis. Biomedical Chromatography 15: 493-497.
16. Dawidowicz, A.L.; and R. Kalityński. 2003. HPLC investigation of free and bound propofol in human plasma and cerebrospinal fluid. Biomedical Chromatography 17: 447-452.
17. Dowrie, R.H.; W.F. Ebling, J.W. Mandema, and D.R. Stanski. 1996. High-performance liquid chromatographic assay of propofol in human and rat plasma and fourteen rat tissues using electrochemical detection. Journal of Chromatography B 678: 279-288.
18. Drummer, O.H. 1992. A fatality due to propofol poisoning. Journal of Forensic Sciences 37: 1186-1189.
19. El-Yazigi, A.; and R.F. Hussein. 1996. Microdetermination of propofol in plasma by a rapid and sensitive liquid chromatographic method. Journal of Pharmaceutical and Biomedical Analysis 15: 99-104.
20. Fritz, G.A.; and W.E. Niemczyk. 2002. Propofol dependency in a lay person. Anesthesiology 96: 505-506.
21. Guitton, J.; M. Desage, A. Lepape, C.S. Degoute, M. Manchon, and J.-L. Brazier. 1995. Quantitation of propofol in whole blood by gas chromatography-mass spectrometry. Journal of Chromatography B 669: 358-365.
22. Iwersen-Bergmann, S.; P. Rösner, H.C. Kühnau, M. Junge, and A. Schmoldt. 2001. Death after excessive propofol abuse. International Journal of Legal Medicine 114: 248-251.
23. Klausz, G.; K. Róna, I. Kristóf, and K. Töro. 2009. Evaluation of a fatal propofol intoxication due to self administration. Journal of Forensic and Legal Medicine 16: 287-289.
24. Knibbe, C.A.; V.S. Koster, V.H. Deneer, R.M. Stuurman, P.F. Kuks, and R. Lange. 1998. Determination of propofol in low-volume samples by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B 706: 305-310.
25. Kranioti, E.F.; A. Mavroforou, P. Mylonakis, and M. Michalodimitrakis. 2007. Lethal self administration of propofol (Diprivan). A case report and review of the literature. Forensic Science International 167: 56-58.
26. Lee, J. 2012. Propofol abuse in professionals. Journal of Korean Medical Science 27: 1451-1452.
27. Lee, S.Y.; N.H. Park, E.K. Jeong, J.W. Wi, C.J. Kim, J.Y. Kim, M.K. In, and J. Hong. 2012. Comparison of GC/MS and LC/MS methods for the analysis of propofol and its metabolites in urine. Journal of Chromatography B 900: 1-10.
28. Lesage, M.G.; D. Stafford, and J.R. Glowa. 2000. Abuse liability of the anaesthetic propofol: Self-administration of propofol in rats under fixed-ratio schedules of drug delivery. Psychopharmacology (Berl) 153: 148-154.
29. Molina, D.K. 2010. Handbook of forensic toxicology for medical examiners. FL: CRC press.
30. Park, J.H.; H.J. Kim, and J.S. Seo. 2012. Medicolegal review of deaths related to propofol administration: Analysis of 36 autopsied cases. Korean Journal of Legal Medicine 36: 56-62.
31. Peters, F.T.; J. Jung, T. Kraemer, and H.H. Maurer. 2005. Fast, simple, and validated gas chromatographic-mass spectrometric assay for quantification of drugs relevant to diagnosis of brain death in human blood plasma samples. Therapeutic Drug Monitoring 27: 334-344.
32. Plummer, G.F. 1987. Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B 421: 171-176.
33. Reference blood level list of therapeutic and toxic substances, TIAFT 2011. http://www.tiaft.org/toxic-values. Accessed 12 Oct 2011.
34. Roussin, A.; M. Mirepoix, G. Lassabe, V. Dumestre-Toulet, V. Gardette, J.L. Montastruc, and M. Lapeyre-Mestre. 2006. Death related to a recreational abuse of propofol at therapeutic dose range. British Journal of Anaesthesia 97: 268.
35. Shafer, A.; V.A. Doze, S.L. Shafer, and P.F. White. 1988. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 69: 348-356.
36. Stetson, P.L.; E.F. Domino, and J.R. Sneyd. 1993. Determination of plasma propofol levels using gas chromatography-mass spectrometry with selected-ion monitoring. Journal of Chromatography B 620: 260-267.
37. Teshima, D.; H. Nagahama, K. Makino, Y. Kataoka, and R. Oishi. 2001. Microanalysis of propofol in human serum by semi-microcolumn high-performance liquid chromatography with UV detection and solid-phase extraction. Journal of Clinical Pharmacy and Therapeutics 26: 381-385.
38. Thieme, D.; H. Sachs, G. Schelling, and C. Hornuss. 2009. Formation of the N-methylpyridinium ether derivative of propofol to improve sensitivity, specificity and reproducibility of its detection in blood by liquid chromatography-mass spectrometry. Journal of Chromatography B 877: 4055-4058.
39. Vree, T.B.; A.J. Lagerwerf, C.P. Bleeker, and P.M.R.M. de Grood. 1999. Direct high-performance liquid chromatography determination of propofol and its metabolite quinol with their glucuronide conjugates and preliminary pharmacokinetics in plasma and urine of man. Journal of Chromatography B 721: 217-228.
40. Yarbrough, J.; R. Harvey, and S. Cox. 2012. Determination of propofol using high performance liquid chromatography in whole blood with fluorescence detection. Journal of Chromatographic Science 50: 162-166.
41. Yeganeh, M.H.; and I. Ramzan. 1997. Determination of propofol in rat whole blood and plasma by high-performance liquid chromatography. Journal of Chromatography B 691: 478-482.
42. Zacny, J.P.; J.L. Lichtor, W. Thompson, and J.L. Apfelbaum. 1993a. Propofol at a subanesthetic dose may have abuse potential in healthy volunteers. Anesthesia and Analgesia 77: 542-544.
43. Zacny, J.P.; J.L. Lichtor, J.G. Zaragoza, D.W. Coalson, A.M. Uitvlugt, D.C. Flemming, W.B. Binstock, T. Cutter, and J.L. Apfelbaum. 1993b. Assessing the behavioral effects and abuse potential of propofol bolus injections in healthy volunteers. Drug and Alcohol Dependence 32: 45-57.